James V Cassella Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James V Cassella.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James V Cassella. James V Cassella is a SVP, Research & Development in Alexza Pharmaceuticals Inc. ($ALXA) and a Chief Development Officer in CONCERT PHARMACEUTICALS, INC. ($CNCE) and a Director in Trevi Therapeutics, Inc. ($TRVI).
Address: ALEXZA PHARMACEUTICALS INC. 1020 E MEADOW CIRCLE PALO ALTO 94303 CA
Companies in which James V Cassella is an Insider
Alexza Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James V Cassella: SVP, Research & Development
Holdings: 0 shares
Latest Transaction: Jan 08 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CONCERT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James V Cassella: Chief Development Officer
Holdings: 94,064 shares
Current Value: $841,873
Latest Transaction: Feb 17 2021
$CNCE Market Capitalization: $197.12M
$CNCE Previous Close: $8.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Trevi Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James V Cassella: Director
Holdings: 0 shares
Latest Transaction: Feb 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James V Cassella
Sentiment: All, ALXA, CNCE, TRVI
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Sell | S | 7.32 | 3,763 | 27,545 | 94,064 | 97.8 K to 94.1 K (-3.85 %) |
| Jan 07 2021 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Option Exercise | A | 13.07 | 60,400 | 789,428 | 60,400 | |
| Jan 07 2021 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Grant | A | 0.00 | 21,700 | 0 | 97,827 | 76.1 K to 97.8 K (+28.50 %) |
| Aug 19 2020 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Sell | S | 10.37 | 4,354 | 45,151 | 76,127 | 80.5 K to 76.1 K (-5.41 %) |
| Feb 19 2020 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Option Exercise | A | 10.87 | 42,430 | 461,214 | 42,430 | |
| Feb 19 2020 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Grant | A | 0.00 | 28,216 | 0 | 80,481 | 52.3 K to 80.5 K (+53.99 %) |
| Feb 18 2020 | TRVI | Trevi Therapeutics ... | Cassella James V | Director | Option Exercise | A | 5.50 | 23,684 | 130,262 | 23,684 |